183 related articles for article (PubMed ID: 35592390)
1. Inhibition of MEK-ERK pathway enhances oncolytic vaccinia virus replication in doxorubicin-resistant ovarian cancer.
Lee S; Yang W; Kim DK; Kim H; Shin M; Choi KU; Suh DS; Kim YH; Hwang TH; Kim JH
Mol Ther Oncolytics; 2022 Jun; 25():211-224. PubMed ID: 35592390
[TBL] [Abstract][Full Text] [Related]
2. Embelin Promotes Oncolytic Vaccinia Virus-Mediated Antitumor Immunity Through Disruption of IL-6/STAT3 Signaling in Lymphoma.
Wang P; Wu Y; Yang C; Zhao G; Liu Y; Cheng G; Wang S
Onco Targets Ther; 2020; 13():1421-1429. PubMed ID: 32110041
[TBL] [Abstract][Full Text] [Related]
3. lncRNA UCA1-Mediated Cdc42 Signaling Promotes Oncolytic Vaccinia Virus Cell-to-Cell Spread in Ovarian Cancer.
Horita K; Kurosaki H; Nakatake M; Kuwano N; Oishi T; Itamochi H; Sato S; Kono H; Ito M; Hasegawa K; Harada T; Nakamura T
Mol Ther Oncolytics; 2019 Jun; 13():35-48. PubMed ID: 31011626
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA UCA1 enhances sensitivity to oncolytic vaccinia virus by sponging miR-18a/miR-182 and modulating the Cdc42/filopodia axis in colorectal cancer.
Horita K; Kurosaki H; Nakatake M; Ito M; Kono H; Nakamura T
Biochem Biophys Res Commun; 2019 Aug; 516(3):831-838. PubMed ID: 31262449
[TBL] [Abstract][Full Text] [Related]
5. Enhancing therapeutic efficacy of oncolytic vaccinia virus armed with Beclin-1, an autophagic Gene in leukemia and myeloma.
Lei W; Wang S; Xu N; Chen Y; Wu G; Zhang A; Chen X; Tong Y; Qian W
Biomed Pharmacother; 2020 May; 125():110030. PubMed ID: 32187960
[TBL] [Abstract][Full Text] [Related]
6. Engineering oncolytic vaccinia virus with functional peptides through mild and universal strategy.
Huang LL; Li X; Liu K; Zou B; Xie HY
Anal Bioanal Chem; 2019 Feb; 411(4):925-933. PubMed ID: 30523361
[TBL] [Abstract][Full Text] [Related]
7. Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancer.
Sun F; Guo ZS; Gregory AD; Shapiro SD; Xiao G; Qu Z
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461344
[TBL] [Abstract][Full Text] [Related]
8. CD19-targeted BiTE expression by an oncolytic vaccinia virus significantly augments therapeutic efficacy against B-cell lymphoma.
Lei W; Ye Q; Hao Y; Chen J; Huang Y; Yang L; Wang S; Qian W
Blood Cancer J; 2022 Feb; 12(2):35. PubMed ID: 35228544
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice.
Gil M; Bieniasz M; Seshadri M; Fisher D; Ciesielski MJ; Chen Y; Pandey RK; Kozbor D
Br J Cancer; 2011 Nov; 105(10):1512-21. PubMed ID: 21989183
[TBL] [Abstract][Full Text] [Related]
10. Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virus.
Peng J; Wang S; Fan W; Li S; Wu Y; Mou X; Wang J; Tong X
Onco Targets Ther; 2018; 11():6887-6900. PubMed ID: 30410347
[TBL] [Abstract][Full Text] [Related]
11. Induction of cell death in ovarian cancer cells by doxorubicin and oncolytic vaccinia virus is associated with CREB3L1 activation.
Mistarz A; Graczyk M; Winkler M; Singh PK; Cortes E; Miliotto A; Liu S; Long M; Yan L; Stablewski A; O'Loughlin K; Minderman H; Odunsi K; Rokita H; McGray AJR; Zsiros E; Kozbor D
Mol Ther Oncolytics; 2021 Dec; 23():38-50. PubMed ID: 34632049
[TBL] [Abstract][Full Text] [Related]
12. CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.
Gil M; Komorowski MP; Seshadri M; Rokita H; McGray AJ; Opyrchal M; Odunsi KO; Kozbor D
J Immunol; 2014 Nov; 193(10):5327-37. PubMed ID: 25320277
[TBL] [Abstract][Full Text] [Related]
13. Beclin1‑armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R‑CHOP against lymphoma in vitro and in vivo.
Xie S; Fan W; Yang C; Lei W; Pan H; Tong X; Wu Y; Wang S
Oncol Rep; 2021 Mar; 45(3):987-996. PubMed ID: 33469679
[TBL] [Abstract][Full Text] [Related]
14. Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase.
Islam SMBU; Lee B; Jiang F; Kim EK; Ahn SC; Hwang TH
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963415
[TBL] [Abstract][Full Text] [Related]
15. Direct imaging and automatic analysis in tumor-on-chip reveal cooperative antitumoral activity of immune cells and oncolytic vaccinia virus.
Mencattini A; Lansche C; Veith I; Erbs P; Balloul JM; Quemeneur E; Descroix S; Mechta-Grigoriou F; Zalcman G; Zaupa C; Parrini MC; Martinelli E
Biosens Bioelectron; 2022 Nov; 215():114571. PubMed ID: 35932554
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of recombinant oncolytic vaccinia virus with human IL2.
Liu L; Li H; Xu Q; Wu Y; Chen D; Yu F
Open Med (Wars); 2022; 17(1):1084-1091. PubMed ID: 35799600
[TBL] [Abstract][Full Text] [Related]
17. Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus with MEK Inhibitor Trametinib in Some BRAF or KRAS-Mutated Colorectal or Lung Carcinoma Models.
Zhou X; Zhao J; Zhang JV; Wu Y; Wang L; Chen X; Ji D; Zhou GG
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578339
[TBL] [Abstract][Full Text] [Related]
18. The MEK/ERK/miR-21 Signaling Is Critical in Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells.
Huang WC; Yadav VK; Cheng WH; Wang CH; Hsieh MS; Huang TY; Lin SF; Yeh CT; Kuo KT
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885115
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene.
Chalikonda S; Kivlen MH; O'Malley ME; Eric Dong XD; McCart JA; Gorry MC; Yin XY; Brown CK; Zeh HJ; Guo ZS; Bartlett DL
Cancer Gene Ther; 2008 Feb; 15(2):115-25. PubMed ID: 18084242
[TBL] [Abstract][Full Text] [Related]
20. MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation.
Bommareddy PK; Aspromonte S; Zloza A; Rabkin SD; Kaufman HL
Sci Transl Med; 2018 Dec; 10(471):. PubMed ID: 30541787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
